The global peanut allergy treatment market size is expected to reach USD 1.01 billion by 2030. The market is expected to grow at a CAGR of 11.82% from 2024 to 2030. Some of the key factors propelling the market growth include a robust product pipeline, high disease prevalence, advancement in the drug delivery system, and strategic initiatives by key players.
Key market players are bolstering their pipeline for peanut allergy treatment through various strategies. For instance, Aravax initiated its series B funding round in December 2022, securing a USD 20 million investment from renowned Australian healthcare entrepreneurs Tenmile and Brandon Capital. This financing will enable Aravax to commence phase II clinical trials of PVX108, targeting individuals who experience allergic reactions to peanuts. Such fundings are expected to drive advancements in research and development programs.
The market is stimulated by the increasing number of product approvals for peanut allergy treatment. In January 2020, the U.S. Food and Drug Administration (FDA) granted authorization to PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], developed by Aimmune Therapeutics, Inc. PALFORZIA is the first immunotherapy medication approved for individuals with peanut allergies. It is an oral immune therapy designed to reduce allergy responses, including anaphylaxis triggered by accidental peanut ingestion. It is intended for individuals who have a confirmed allergy, with initial dose escalation recommended for children aged four to 17.
As of the first quarter of 2023, several promising pipeline products are undergoing clinical development. These include Viaskin Peanut by DBV Technologies, CA002 by Dupixient, and Camallegr, a collaborative effort between Sanofi and Regeneron. Additionally, other assets such as ADP101, VE416, INP20, and CNP-201 are also in development. The introduction of these medications is anticipated to contribute to the growth and expansion of the market during the projected forecast period.
Key market players are bolstering their pipeline for peanut allergy treatment through various strategies. For instance, Aravax initiated its series B funding round in December 2022, securing a USD 20 million investment from renowned Australian healthcare entrepreneurs Tenmile and Brandon Capital. This financing will enable Aravax to commence phase II clinical trials of PVX108, targeting individuals who experience allergic reactions to peanuts. Such fundings are expected to drive advancements in research and development programs.
The market is stimulated by the increasing number of product approvals for peanut allergy treatment. In January 2020, the U.S. Food and Drug Administration (FDA) granted authorization to PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], developed by Aimmune Therapeutics, Inc. PALFORZIA is the first immunotherapy medication approved for individuals with peanut allergies. It is an oral immune therapy designed to reduce allergy responses, including anaphylaxis triggered by accidental peanut ingestion. It is intended for individuals who have a confirmed allergy, with initial dose escalation recommended for children aged four to 17.
As of the first quarter of 2023, several promising pipeline products are undergoing clinical development. These include Viaskin Peanut by DBV Technologies, CA002 by Dupixient, and Camallegr, a collaborative effort between Sanofi and Regeneron. Additionally, other assets such as ADP101, VE416, INP20, and CNP-201 are also in development. The introduction of these medications is anticipated to contribute to the growth and expansion of the market during the projected forecast period.
Peanut Allergy Treatment Market Report Highlights
- The epinephrine segment held the major market share in 2023. The standard of care for anaphylaxis treatment has been epinephrine auto-injectors, which are also essential in the management of allergies in emergency situations
- By route of administration, the injectable segment dominated the market in 2023 owing to the development of injectable treatments that are practical, less painful, and easier to use for patients is being pursued in response to the growing emphasis on patient-centered care. This includes looking at alternative delivery systems for injectable therapies, such as wearable technology or auto-injectors
- By distribution channel, the hospital pharmacy segment held the largest market share in 2023. Hospital pharmacies put more of an emphasis on offering patient support and information for people with peanut allergies
- North America has established a strong regional position in the market. This is due to the presence of numerous pharmaceutical companies, academic institutions, and research organizations currently looking into new therapeutic strategies to address the underlying causes of peanut allergies, including gene therapy, biologics, and other immunomodulatory interventions
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Drug Class and Route of Administration Snapshot
2.3. Distribution Channel Snapshot
2.4. Competitive Landscape Snapshot
2.2. Drug Class and Route of Administration Snapshot
2.3. Distribution Channel Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising product approvals for the treatment of peanut allergy
3.4.2. Increasing prevalence of peanut allergies
3.4.3. Increasing healthcare expenditure
3.5. Market Restraint Analysis
3.5.1. High cost of the treatment and the products
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.7. COVID-19 Impact Analysis
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising product approvals for the treatment of peanut allergy
3.4.2. Increasing prevalence of peanut allergies
3.4.3. Increasing healthcare expenditure
3.5. Market Restraint Analysis
3.5.1. High cost of the treatment and the products
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.7. COVID-19 Impact Analysis
Chapter 4. Route Of Administration Business Analysis
4.1. Peanut Allergy Treatment Market: Route Of Administration Movement Analysis
4.2. Oral
4.2.1. Oral Market, 2018-2030 (USD Million)
4.3. Injectable
4.3.1. Injectable Market, 2018-2030 (USD Million)
4.4. Others
4.4.1. Others Market, 2018-2030 (USD Million)
4.2. Oral
4.2.1. Oral Market, 2018-2030 (USD Million)
4.3. Injectable
4.3.1. Injectable Market, 2018-2030 (USD Million)
4.4. Others
4.4.1. Others Market, 2018-2030 (USD Million)
Chapter 5. Drug Class Business Analysis
5.1. Peanut Allergy Treatment Market: Drug Class Movement Analysis
5.2. Antihistamines
5.2.1. Antihistamines Market, 2018-2030 (USD Million)
5.3. Epinephrine
5.3.1. Epinephrine Market, 2018-2030 (USD Million)
5.4. Immunotherapies
5.4.1. Immunotherapies Market, 2018-2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018-2030 (USD Million)
5.2. Antihistamines
5.2.1. Antihistamines Market, 2018-2030 (USD Million)
5.3. Epinephrine
5.3.1. Epinephrine Market, 2018-2030 (USD Million)
5.4. Immunotherapies
5.4.1. Immunotherapies Market, 2018-2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018-2030 (USD Million)
Chapter 6. Distribution Channel Business Analysis
6.1. Peanut Allergy Treatment Market: Distribution Channel Movement Analysis
6.2. Hospital Pharmacy
6.2.1. Hospital Pharmacy Market, 2018-2030 (USD Million)
6.3. Retail Pharmacy
6.3.1. Retail Pharmacy Market, 2018-2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018-2030 (USD Million)
6.2. Hospital Pharmacy
6.2.1. Hospital Pharmacy Market, 2018-2030 (USD Million)
6.3. Retail Pharmacy
6.3.1. Retail Pharmacy Market, 2018-2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018-2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Peanut Allergy Treatment Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Peanut Allergy Treatment Market, 2018-2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. U.S. Peanut Allergy Treatment market, 2018-2030 (USD MILLION)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Reimbursement Scenario
7.2.4.6. Canada Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. Germany Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.4. UK
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. UK Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. France Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Italy Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Spain Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Denmark Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Sweden Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Norway Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. SWOT Analysis
7.4.2. Asia-Pacific Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. Japan Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. China Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. India Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.6. South Korea
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. South Korea Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Australia Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.8. Thailand
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. Thailand Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Brazil Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Mexico Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Argentina Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. South Africa Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. Saudi Arabia Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. UAE Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Kuwait Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Peanut Allergy Treatment Market, 2018-2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. U.S. Peanut Allergy Treatment market, 2018-2030 (USD MILLION)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Reimbursement Scenario
7.2.4.6. Canada Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. Germany Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.4. UK
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. UK Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. France Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Italy Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Spain Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Denmark Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Sweden Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Norway Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. SWOT Analysis
7.4.2. Asia-Pacific Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. Japan Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. China Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. India Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.6. South Korea
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. South Korea Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Australia Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.4.8. Thailand
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. Thailand Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Brazil Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Mexico Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Argentina Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. South Africa Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. Saudi Arabia Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. UAE Peanut Allergy Treatment market, 2018-2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Kuwait Peanut Allergy Treatment market, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant’s overview
8.2. Financial performance
8.3. Participant categorization
8.3.1. Market Leaders
8.3.2. Peanut Allergy Treatment market Share Analysis, 2023
8.3.3. Company Profiles
8.3.3.1. Sanofi
8.3.3.1.1. Company Overview
8.3.3.1.2. Financial Performance
8.3.3.1.3. Product Benchmarking
8.3.3.1.4. Strategic Initiatives
8.3.3.2. Aimmune Therapeutics Inc.
8.3.3.2.1. Company Overview
8.3.3.2.2. Financial Performance
8.3.3.2.3. Product Benchmarking
8.3.3.2.4. Strategic Initiatives
8.3.3.3. DBV Technologies
8.3.3.3.1. Company Overview
8.3.3.3.2. Financial Performance
8.3.3.3.3. Product Benchmarking
8.3.3.3.4. Strategic Initiatives
8.3.3.4. Vedanta Biosciences, Inc.
8.3.3.4.1. Company Overview
8.3.3.4.2. Financial Performance
8.3.3.4.3. Product Benchmarking
8.3.3.4.4. Strategic Initiatives
8.3.3.5. Alladapt Immunotherapeutics, Inc.
8.3.3.5.1. Company Overview
8.3.3.5.2. Financial Performance
8.3.3.5.3. Product Benchmarking
8.3.3.5.4. Strategic Initiatives
8.3.3.6. Regeneron Pharmaceuticals Inc.
8.3.3.6.1. Company Overview
8.3.3.6.2. Financial Performance
8.3.3.6.3. Product Benchmarking
8.3.3.6.4. Strategic Initiatives
8.3.3.7. Aravax Pty Ltd
8.3.3.7.1. Company Overview
8.3.3.7.2. Financial Performance
8.3.3.7.3. Product Benchmarking
8.3.3.7.4. Strategic Initiatives
8.3.3.8. Prota Therapeutics
8.3.3.8.1. Company Overview
8.3.3.8.2. Financial Performance
8.3.3.8.3. Product Benchmarking
8.3.3.8.4. Strategic Initiatives
8.3.3.9. Teva Pharmaceuticals Industries Ltd.
8.3.3.9.1. Company Overview
8.3.3.9.2. Financial Performance
8.3.3.9.3. Product Benchmarking
8.3.3.9.4. Strategic Initiatives
8.3.4. Strategy Mapping
8.3.4.1. Expansion
8.3.4.2. Acquisition
8.3.4.3. Collaborations
8.3.4.4. Route Of Administration/Drug Class Launch
8.3.4.5. Partnerships
8.3.4.6. Others
8.2. Financial performance
8.3. Participant categorization
8.3.1. Market Leaders
8.3.2. Peanut Allergy Treatment market Share Analysis, 2023
8.3.3. Company Profiles
8.3.3.1. Sanofi
8.3.3.1.1. Company Overview
8.3.3.1.2. Financial Performance
8.3.3.1.3. Product Benchmarking
8.3.3.1.4. Strategic Initiatives
8.3.3.2. Aimmune Therapeutics Inc.
8.3.3.2.1. Company Overview
8.3.3.2.2. Financial Performance
8.3.3.2.3. Product Benchmarking
8.3.3.2.4. Strategic Initiatives
8.3.3.3. DBV Technologies
8.3.3.3.1. Company Overview
8.3.3.3.2. Financial Performance
8.3.3.3.3. Product Benchmarking
8.3.3.3.4. Strategic Initiatives
8.3.3.4. Vedanta Biosciences, Inc.
8.3.3.4.1. Company Overview
8.3.3.4.2. Financial Performance
8.3.3.4.3. Product Benchmarking
8.3.3.4.4. Strategic Initiatives
8.3.3.5. Alladapt Immunotherapeutics, Inc.
8.3.3.5.1. Company Overview
8.3.3.5.2. Financial Performance
8.3.3.5.3. Product Benchmarking
8.3.3.5.4. Strategic Initiatives
8.3.3.6. Regeneron Pharmaceuticals Inc.
8.3.3.6.1. Company Overview
8.3.3.6.2. Financial Performance
8.3.3.6.3. Product Benchmarking
8.3.3.6.4. Strategic Initiatives
8.3.3.7. Aravax Pty Ltd
8.3.3.7.1. Company Overview
8.3.3.7.2. Financial Performance
8.3.3.7.3. Product Benchmarking
8.3.3.7.4. Strategic Initiatives
8.3.3.8. Prota Therapeutics
8.3.3.8.1. Company Overview
8.3.3.8.2. Financial Performance
8.3.3.8.3. Product Benchmarking
8.3.3.8.4. Strategic Initiatives
8.3.3.9. Teva Pharmaceuticals Industries Ltd.
8.3.3.9.1. Company Overview
8.3.3.9.2. Financial Performance
8.3.3.9.3. Product Benchmarking
8.3.3.9.4. Strategic Initiatives
8.3.4. Strategy Mapping
8.3.4.1. Expansion
8.3.4.2. Acquisition
8.3.4.3. Collaborations
8.3.4.4. Route Of Administration/Drug Class Launch
8.3.4.5. Partnerships
8.3.4.6. Others
List of Tables
Table 1 List of Abbreviations
Table 2 Global Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 3 Global Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 4 Global Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 5 Global Peanut Allergy Treatment Market, by Region, 2018-2030 (USD Million)
Table 6 North America peanut Allergy Treatment Market, by Country, 2018-2030 (USD Million)
Table 7 North America peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 8 North America peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 9 North America peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 10 U.S. Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 11 U.S. Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 12 U.S. Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 13 Canada Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 14 Canada Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 15 Canada Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 16 Europe Peanut Allergy Treatment Market, by Country, 2018-2030 (USD Million)
Table 17 Europe Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 18 Europe peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 19 Europe peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 20 Germany Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 21 Germany Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 22 Germany Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 23 UK Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 24 UK Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 25 UK Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 26 France Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 27 France Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 28 France Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 29 Italy Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 30 Italy Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 31 Italy Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 32 Spain Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 33 Spain Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 34 Spain Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 35 Denmark Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 36 Denmark Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 37 Denmark Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 38 Sweden Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 39 Sweden Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 40 Sweden Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 41 Norway Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 42 Norway Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 43 Norway Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 44 Asia-Pacific peanut Allergy Treatment Market, by Country, 2018-2030 (USD Million)
Table 45 Asia-Pacific peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 46 Asia-Pacific peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 47 Asia-Pacific peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 48 China Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 49 China Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 50 China Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 51 Japan Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 52 Japan Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 53 Japan Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 54 India Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 55 India Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 56 India Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 57 South Korea Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 58 South Korea Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 59 South Korea Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 60 Australia Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 61 Australia Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 62 Australia Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 63 Thailand Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 64 Thailand Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 65 Thailand Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 66 Latin America peanut Allergy Treatment Market, by Country, 2018-2030 (USD Million)
Table 67 Latin America peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 68 Latin America peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 69 Latin America peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 70 Brazil Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 71 Brazil Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 72 Brazil Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 73 Mexico Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 74 Mexico Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 75 Mexico Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 76 Argentina Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 77 Argentina Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 78 Argentina Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 79 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 80 Middle East & Africa peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 81 Middle East & Africa peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 82 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 83 South Africa Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 84 South Africa Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 85 South Africa Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 86 Saudi Arabia Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 87 Saudi Arabia Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 88 Saudi Arabia Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 89 UAE Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 90 UAE Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 91 UAE Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 92 Kuwait Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 93 Kuwait Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 94 Kuwait Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 2 Global Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 3 Global Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 4 Global Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 5 Global Peanut Allergy Treatment Market, by Region, 2018-2030 (USD Million)
Table 6 North America peanut Allergy Treatment Market, by Country, 2018-2030 (USD Million)
Table 7 North America peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 8 North America peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 9 North America peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 10 U.S. Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 11 U.S. Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 12 U.S. Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 13 Canada Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 14 Canada Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 15 Canada Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 16 Europe Peanut Allergy Treatment Market, by Country, 2018-2030 (USD Million)
Table 17 Europe Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 18 Europe peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 19 Europe peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 20 Germany Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 21 Germany Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 22 Germany Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 23 UK Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 24 UK Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 25 UK Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 26 France Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 27 France Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 28 France Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 29 Italy Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 30 Italy Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 31 Italy Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 32 Spain Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 33 Spain Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 34 Spain Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 35 Denmark Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 36 Denmark Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 37 Denmark Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 38 Sweden Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 39 Sweden Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 40 Sweden Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 41 Norway Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 42 Norway Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 43 Norway Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 44 Asia-Pacific peanut Allergy Treatment Market, by Country, 2018-2030 (USD Million)
Table 45 Asia-Pacific peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 46 Asia-Pacific peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 47 Asia-Pacific peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 48 China Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 49 China Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 50 China Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 51 Japan Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 52 Japan Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 53 Japan Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 54 India Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 55 India Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 56 India Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 57 South Korea Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 58 South Korea Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 59 South Korea Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 60 Australia Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 61 Australia Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 62 Australia Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 63 Thailand Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 64 Thailand Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 65 Thailand Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 66 Latin America peanut Allergy Treatment Market, by Country, 2018-2030 (USD Million)
Table 67 Latin America peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 68 Latin America peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 69 Latin America peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 70 Brazil Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 71 Brazil Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 72 Brazil Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 73 Mexico Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 74 Mexico Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 75 Mexico Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 76 Argentina Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 77 Argentina Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 78 Argentina Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 79 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 80 Middle East & Africa peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 81 Middle East & Africa peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 82 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 83 South Africa Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 84 South Africa Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 85 South Africa Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 86 Saudi Arabia Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 87 Saudi Arabia Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 88 Saudi Arabia Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 89 UAE Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 90 UAE Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 91 UAE Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 92 Kuwait Peanut Allergy Treatment Market, by Route Of Administration, 2018-2030 (USD Million)
Table 93 Kuwait Peanut Allergy Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 94 Kuwait Peanut Allergy Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Peanut allergy treatment market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain based sizing & forecasting
Figure 7 QFD modelling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Route of administration and distribution channel segment snapshot
Figure 11 Drug class segment snapshot
Figure 12 Competitive landscape snapshot
Figure 13 Allergy diagnostics and therapeutics market value, 2023 (USD billion)
Figure 14 Market dynamics
Figure 15 Porter’s five forces analysis
Figure 16 PESTLE analysis
Figure 17 KOLs perspective
Figure 18 KOLs perspective
Figure 19 KOLs perspective
Figure 20 Peanut allergy treatment market: Route of administration outlook and key takeaways
Figure 21 Peanut allergy treatment market: Route of administration movement analysis
Figure 22 Injectable market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Oral market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Peanut allergy treatment market: Drug class outlook and key takeaways
Figure 26 Peanut allergy treatment market: Drug class movement analysis
Figure 27 Antihistamines market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Epinephrine market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Immunotherapies market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Peanut allergy treatment market: Distribution channel outlook and key takeaways
Figure 32 Peanut allergy treatment market: Distribution channel movement analysis
Figure 33 Hospital pharmacy market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Retail pharmacy market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Peanut allergy treatment market revenue, by region, 2023 & 2030 (USD Million)2023 & 2030 (USD Million)2023 & 2030 (USD Million)
Figure 37 Regional marketplace: Key takeaways
Figure 38 Regional marketplace: Key takeaways
Figure 39 North America peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Key country dynamics
Figure 41 U.S. peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 U.S. healthcare system: Money flow
Figure 43 Key country dynamics
Figure 44 Canada peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Drug pricing
Figure 65 Asia-Pacific peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 Japan peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 68 Japan pharmaceutical registration
Figure 69 Key country dynamics
Figure 70 China peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 71 Regulatory details: China
Figure 72 Exclusivity formula
Figure 73 Key country dynamics
Figure 74 India peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 75 Registration details: India
Figure 76 Key country dynamics
Figure 77 Australia peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Drug pricing: Australia
Figure 79 Contribution of PBS by disease
Figure 80 Key country dynamics
Figure 81 Thailand peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 South Korea peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 84 Reimbursement scenario: South Korea
Figure 85 Rest of Asia-Pacific peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 86 Latin America peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 87 Key country dynamics
Figure 88 Brazil peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 89 Key country dynamics
Figure 90 Mexico peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 91 Regulatory framework
Figure 92 Reimbursement scenario
Figure 93 Key country dynamics
Figure 94 Argentina peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 95 Argentina pharmaceuticals registration details
Figure 96 Argentina pharmaceuticals reimbursement details
Figure 97 Rest of Latin America peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 98 Middle East and Africa peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 99 Key country dynamics
Figure 100 South Africa peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 101 Regulatory framework: South Africa
Figure 102 Regulatory framework: South Africa drug registration fees
Figure 103 Key country dynamics
Figure 104 Saudi Arabia peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 105 Key country dynamics
Figure 106 UAE peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 107 Key country dynamics
Figure 108 Kuwait peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 109 Regulatory framework: South Africa
Figure 110 Rest of MEA peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain based sizing & forecasting
Figure 7 QFD modelling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Route of administration and distribution channel segment snapshot
Figure 11 Drug class segment snapshot
Figure 12 Competitive landscape snapshot
Figure 13 Allergy diagnostics and therapeutics market value, 2023 (USD billion)
Figure 14 Market dynamics
Figure 15 Porter’s five forces analysis
Figure 16 PESTLE analysis
Figure 17 KOLs perspective
Figure 18 KOLs perspective
Figure 19 KOLs perspective
Figure 20 Peanut allergy treatment market: Route of administration outlook and key takeaways
Figure 21 Peanut allergy treatment market: Route of administration movement analysis
Figure 22 Injectable market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Oral market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Peanut allergy treatment market: Drug class outlook and key takeaways
Figure 26 Peanut allergy treatment market: Drug class movement analysis
Figure 27 Antihistamines market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Epinephrine market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Immunotherapies market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Peanut allergy treatment market: Distribution channel outlook and key takeaways
Figure 32 Peanut allergy treatment market: Distribution channel movement analysis
Figure 33 Hospital pharmacy market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Retail pharmacy market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Peanut allergy treatment market revenue, by region, 2023 & 2030 (USD Million)2023 & 2030 (USD Million)2023 & 2030 (USD Million)
Figure 37 Regional marketplace: Key takeaways
Figure 38 Regional marketplace: Key takeaways
Figure 39 North America peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Key country dynamics
Figure 41 U.S. peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 U.S. healthcare system: Money flow
Figure 43 Key country dynamics
Figure 44 Canada peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Drug pricing
Figure 65 Asia-Pacific peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 Japan peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 68 Japan pharmaceutical registration
Figure 69 Key country dynamics
Figure 70 China peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 71 Regulatory details: China
Figure 72 Exclusivity formula
Figure 73 Key country dynamics
Figure 74 India peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 75 Registration details: India
Figure 76 Key country dynamics
Figure 77 Australia peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Drug pricing: Australia
Figure 79 Contribution of PBS by disease
Figure 80 Key country dynamics
Figure 81 Thailand peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 South Korea peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 84 Reimbursement scenario: South Korea
Figure 85 Rest of Asia-Pacific peanut allergy treatment market estimates and forecast, 2018-2030 (USD Million)
Figure 86 Latin America peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 87 Key country dynamics
Figure 88 Brazil peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 89 Key country dynamics
Figure 90 Mexico peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 91 Regulatory framework
Figure 92 Reimbursement scenario
Figure 93 Key country dynamics
Figure 94 Argentina peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 95 Argentina pharmaceuticals registration details
Figure 96 Argentina pharmaceuticals reimbursement details
Figure 97 Rest of Latin America peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 98 Middle East and Africa peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 99 Key country dynamics
Figure 100 South Africa peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 101 Regulatory framework: South Africa
Figure 102 Regulatory framework: South Africa drug registration fees
Figure 103 Key country dynamics
Figure 104 Saudi Arabia peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 105 Key country dynamics
Figure 106 UAE peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 107 Key country dynamics
Figure 108 Kuwait peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Figure 109 Regulatory framework: South Africa
Figure 110 Rest of MEA peanut allergy treatment market estimates and forecasts, 2018-2030 (USD Million)
Companies Mentioned
- Sanofi
- Aimmune Therapeutics Inc.
- DBV Technologies
- Vedanta Biosciences, Inc.
- Alladapt Immunotherapeutics, Inc.
- Regeneron Pharmaceuticals Inc.
- Aravax Pty Ltd
- Prota Therapeutics
- Teva Pharmaceuticals Industries Ltd.
Methodology
LOADING...
